ArticleVirology journal2025
Biochemical and functional characterization of orf virus decapping protein OV71.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundNudix enzymes constitute a family of hydrolases that share a conserved Nudix motif, which catalyzes the hydrolysis of nucleoside diphosphates linked to another moiety X. Some members are cellular and viral decapping enzymes that hydrolyze the 5´ cap structure on an mRNA molecule. Unlike vaccinia virus, which encodes two Nudix enzymes, orf virus (ORFV) encodes only a single Nudix-containing gene, ORFV071 (OV71). This study investigates the biochemical properties of recombinant OV71 protein and its role in viral replication.
methodsIn vitro decapping assays using radiolabeled capped RNA substrates were performed to assess OV71 activity in the presence or absence of competitors or metal cations. Electrophoretic mobility shift assays and pulldown assays evaluated the RNA-binding ability of OV71. Decapping-deficient mutant viruses were generated by homologous recombination, and their replication was analyzed using one-step growth curve experiments. Reverse transcription-qPCR quantified host and viral mRNA levels.
resultsOV71 exhibited intrinsic decapping activity, hydrolyzing long capped RNAs to release m
conclusionOV71 is a decapping enzyme that hydrolyzes the cap structure on long capped mRNAs. It binds both single- and double-stranded RNA, suggesting that it may target both RNA species in infected cells. Its decapping activity is critical for efficient orf virus replication. Loss of this activity leads to the accumulation of host-capped mRNAs, a drastic reduction of viral mRNAs, and minimal impact on host rRNAs, indicating a role distinct from that of the vaccinia virus decapping enzymes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.